Presentation by Andy Cairns, Programme Manager, Innovation Agency: Welcome and introduction at the Funding - Liverpool City Region SME workshop on Thursday 7 February 2019 at The Accelerator, Liverpool
Andy Cairns - Access to Funding Liverpool SME WorkshopInnovation Agency
This document summarizes a funding workshop that discussed various national and European funding opportunities for innovation. It outlines several programs, including:
1) The SBRI Healthcare program which provides up to £100,000 for feasibility studies and up to £1 million for development projects.
2) The Innovation and Technology Payment which aims to support adoption of innovative products and technologies by removing financial barriers.
3) Horizon 2020 and the SME Instrument which provides up to €2.5 million for highly innovative SMEs with global ambitions.
4) Eurostars which provides funding for transnational R&D projects led by SMEs in at least two Eurostars countries.
The workshop emphasized being realistic about
Karen Livingstone - ECO 17: Transforming care through digital healthInnovation Agency
The document discusses the Innovation Exchange and SBRI Healthcare programs which aim to accelerate the development and adoption of innovative healthcare solutions in England. It provides background on Karen Livingstone, the director of the programs. It then outlines key forces shaping global healthcare and describes the 15 Academic Health Science Networks that work locally and nationally to drive innovation adoption across England. The rest of the document details how the Innovation Exchange identifies healthcare needs and supports companies through funding competitions, needs assessments, and providing support to help ready solutions for adoption across the NHS. It provides examples of companies it has supported in areas like patient engagement, chronic condition management, and early disease detection.
The Office for Life Sciences (OLS) in partnership with Innovate UK is working to support developers of innovative medical devices, diagnostics and regulated digital health products to evaluate their products in a real-world clinical setting. Funding is being made available through a series of competitions that will run over the next 2 years. The first round of the competition was run in early 2018.
The second round of the competition ‘Support for SMEs to evaluate innovative medical technologies competition’ opened on 2 July. Up to £1.5m funding is available to support small and medium-sized enterprises (SMEs) generate an evidence base that will enable the evaluation of products that address priorities areas for NHS England. This support is intended to allow companies to collect and analyse clinical performance and cost effectiveness data within an NHS setting.
Watch the webcast via KTN's YouTube channel: https://www.youtube.com/c/KnowledgeTransferNetwork
This document provides information about the UK Research and Innovation Digital Health Technology Catalyst Round 2 competition. It discusses the UK's industrial strategy and focus on digital health. The competition will invest up to £8 million to fund collaborative industrial research and experimental development projects between small/medium businesses and other organizations. Projects must use digital technologies like AI, VR, sensors and data analytics to improve health outcomes, transform healthcare delivery or control costs. Details are provided on funding amounts, eligibility requirements, project scope and timelines. Interested applicants are encouraged to check the Innovate UK website and attend an information webinar.
Presentation by Mike Kenny, Associate Commercial Director, Innovation Agency at the Health Sector Business Breakfast, 16 March at Northwich Memorial Court
General Practice Transformation Champions: Improving Access to General PracticeNHS England
The document discusses plans to improve access to general practice services in England by October 1st, 2018. It outlines that patient satisfaction with making appointments has declined in recent years. The GP Forward View aims to strengthen general practice through extended access to services. All clinical commissioning groups must provide extended access to GP services in the evenings and weekends for 100% of the population by October 2018. The document details the seven core requirements for extended access and over £348 million in funding that has been made available to CCGs to implement the changes.
The impact of New Models of Care on a Health Economy’s Digital StrategyHIMSS UK
This document discusses the key digital implications of new models of care on a health economy's digital strategy. It presents a case study of the Croydon Accountable Provider Alliance (APA) in the UK. The three key digital implications discussed are:
1) Organizational form and governance - The new model of care requires a shared governance structure and independent project management to achieve digital ambitions.
2) Interoperability - The model requires a fully interoperable electronic health record that can be shared across providers and with patients. Options for integration platforms are considered.
3) Analytics - A culture of data-driven decision making is needed. Joint business intelligence services and a focus on population health analytics can improve
Presentation by Andy Cairns, Programme Manager, Innovation Agency: Welcome and introduction at the Funding - Liverpool City Region SME workshop on Thursday 7 February 2019 at The Accelerator, Liverpool
Andy Cairns - Access to Funding Liverpool SME WorkshopInnovation Agency
This document summarizes a funding workshop that discussed various national and European funding opportunities for innovation. It outlines several programs, including:
1) The SBRI Healthcare program which provides up to £100,000 for feasibility studies and up to £1 million for development projects.
2) The Innovation and Technology Payment which aims to support adoption of innovative products and technologies by removing financial barriers.
3) Horizon 2020 and the SME Instrument which provides up to €2.5 million for highly innovative SMEs with global ambitions.
4) Eurostars which provides funding for transnational R&D projects led by SMEs in at least two Eurostars countries.
The workshop emphasized being realistic about
Karen Livingstone - ECO 17: Transforming care through digital healthInnovation Agency
The document discusses the Innovation Exchange and SBRI Healthcare programs which aim to accelerate the development and adoption of innovative healthcare solutions in England. It provides background on Karen Livingstone, the director of the programs. It then outlines key forces shaping global healthcare and describes the 15 Academic Health Science Networks that work locally and nationally to drive innovation adoption across England. The rest of the document details how the Innovation Exchange identifies healthcare needs and supports companies through funding competitions, needs assessments, and providing support to help ready solutions for adoption across the NHS. It provides examples of companies it has supported in areas like patient engagement, chronic condition management, and early disease detection.
The Office for Life Sciences (OLS) in partnership with Innovate UK is working to support developers of innovative medical devices, diagnostics and regulated digital health products to evaluate their products in a real-world clinical setting. Funding is being made available through a series of competitions that will run over the next 2 years. The first round of the competition was run in early 2018.
The second round of the competition ‘Support for SMEs to evaluate innovative medical technologies competition’ opened on 2 July. Up to £1.5m funding is available to support small and medium-sized enterprises (SMEs) generate an evidence base that will enable the evaluation of products that address priorities areas for NHS England. This support is intended to allow companies to collect and analyse clinical performance and cost effectiveness data within an NHS setting.
Watch the webcast via KTN's YouTube channel: https://www.youtube.com/c/KnowledgeTransferNetwork
This document provides information about the UK Research and Innovation Digital Health Technology Catalyst Round 2 competition. It discusses the UK's industrial strategy and focus on digital health. The competition will invest up to £8 million to fund collaborative industrial research and experimental development projects between small/medium businesses and other organizations. Projects must use digital technologies like AI, VR, sensors and data analytics to improve health outcomes, transform healthcare delivery or control costs. Details are provided on funding amounts, eligibility requirements, project scope and timelines. Interested applicants are encouraged to check the Innovate UK website and attend an information webinar.
Presentation by Mike Kenny, Associate Commercial Director, Innovation Agency at the Health Sector Business Breakfast, 16 March at Northwich Memorial Court
General Practice Transformation Champions: Improving Access to General PracticeNHS England
The document discusses plans to improve access to general practice services in England by October 1st, 2018. It outlines that patient satisfaction with making appointments has declined in recent years. The GP Forward View aims to strengthen general practice through extended access to services. All clinical commissioning groups must provide extended access to GP services in the evenings and weekends for 100% of the population by October 2018. The document details the seven core requirements for extended access and over £348 million in funding that has been made available to CCGs to implement the changes.
The impact of New Models of Care on a Health Economy’s Digital StrategyHIMSS UK
This document discusses the key digital implications of new models of care on a health economy's digital strategy. It presents a case study of the Croydon Accountable Provider Alliance (APA) in the UK. The three key digital implications discussed are:
1) Organizational form and governance - The new model of care requires a shared governance structure and independent project management to achieve digital ambitions.
2) Interoperability - The model requires a fully interoperable electronic health record that can be shared across providers and with patients. Options for integration platforms are considered.
3) Analytics - A culture of data-driven decision making is needed. Joint business intelligence services and a focus on population health analytics can improve
Presentation by Matt Chapman, Knowledge Transfer Manager, Knowledge Transfer Network at the Health Sector Business Breakfast, 16 March at Northwich Memorial Court
Dr Hakim Yadi, Chief Executive Officer for Northern Health Science Alliance (NHSA) opened the May 24th Ecosystem event with this introduction to Connected Health Cities in the North West.
Colin Cram, Open Forum Events - Open Forum Events' NHS Commissioning and Proc...Alexis May
The NHS is facing significant financial deficits and must achieve £2 billion in procurement savings by 2015-2016. The current strategy involves national initiatives to standardize contracts for high spending categories and establish a Center of Procurement Efficiency. However, the strategy may not achieve full savings and further reform such as mandatory standardization and an integrated procurement organization may be needed. Significant challenges include trust engagement, data sharing, and ensuring savings are realized at the local level.
Dr Samantha Roberts: Increasing adoption of innovation Innovation Agency
The NHS England Innovation and Life Sciences Division aims to increase adoption of innovation in healthcare. It oversees numerous programs from initial research through national implementation. The division is working to better align these programs, support behaviors that increase adoption, improve the supply of high quality innovations, and understand demand. It hopes to focus on how to spread innovations adaptively rather than through rigid, top-down approaches.
New Funding & Development Opportunities for InnovatorsIsabelle Sparrow
On November 8th GM AHSN invited innovators from the region to an event at the Nowgen Centre in Manchester. The event provided information about some of the current funding and support opportunities available to healthcare innovators, including programmes from GM AHSN's Innovation Nexus, SBRI Healthcare and the Business Growth Hub.
The document discusses trends in digital health technologies and healthy lifestyles. It notes that the global well-being market is $2.9 trillion and growing, with self-care and diagnostics markets increasing 8-12% annually. Many people are using social media and mobile devices to search for health information. The document also outlines some challenges to digital health adoption, such as developing open standards and new business models that combine public/private sectors to empower patients and better integrate prevention and care.
The National Institute for Health Research Collaboration for Leadership in Ap...Richard Harding
This document discusses using funding and partnerships to promote innovation in healthcare technology. It highlights projects in the UK that received funding to develop new technologies, including a children's hospital that leveraged over £13 million for an innovation center. It also describes a competition that provided £500,000 to pilot adoption of new technologies. The document outlines European partnerships and events between countries to support collaboration. It promotes an eHealth cluster to connect businesses, healthcare organizations, and academics. Finally, it discusses challenges of introducing new technologies and the need for organizational changes to accommodate disruptions.
Scaling up innovation in healthcare - A Methodology Framework 2015Marc Lange
This presentation introduce a methodology scaling-up developed by "doers and shapers" internationally known for their expertise in eHealth and digital health
Digital Primary Care Maturity Assurance ModelNHS England
The document introduces England's Digital Primary Care Maturity Assurance Model, which assesses the digital maturity of general practices and clinical commissioning groups (CCGs). It collects 107 indicators on areas like data flows, systems usage, and online services from sources including CCG questionnaires, the GP electronic declaration, and HSCIC reports. The model provides different views of the data to support various national programs and objectives. It aims to help CCGs and practices benchmark their digital capabilities and identify areas for investment and collaboration to advance primary care digitization goals. Future development may include linking to secondary care data, shifting the focus from capabilities to usage, and reflecting new models of integrated care.
Bob Ricketts, NHS England - Open Forum Events' NHS Commissioning and Procurem...Alexis May
The document discusses the challenges facing the NHS, including an aging population, rising rates of chronic diseases, increasing costs and resource constraints. It argues that the NHS needs bold, transformative solutions to reshape services at scale and pace. New commissioning approaches like outcome-based population commissioning are proposed to incentivize integrated care, better outcomes and value. Examples from places like Staffordshire aim to develop new payment models and contracts with lead providers to coordinate care for defined populations.
Introduction to the SBRI Competition: Vaccines for Epidemic DiseasesKTN
This document provides information about an upcoming SBRI (Small Business Research Initiative) competition focused on vaccines for epidemic diseases. It summarizes the agenda for an information session on the competition, including welcome remarks, an overview of the UK Vaccine Network and competition aims, and details about the call and timelines. The competition will provide up to £10 million in funding across multiple projects to enhance clinical and regulatory preparedness of vaccines for UKVN priority pathogens or "Disease X". Applications will be accepted from October 11-November 10, 2021 and contracts are expected to be awarded starting April 1, 2022.
Steve Davies, Crown Commercial Service - Open Forum Events' NHS Commissioning...Alexis May
The Crown Commercial Service (CCS) delivers procurement services for the UK public sector, including health organizations. It plays a key role in centralized procurement, providing significant savings for taxpayers. CCS handles over £2.3 billion in annual procurement for the NHS, its largest partner. As a procurement partner, CCS can provide expertise, strategic sourcing of common commodities, and assist with all stages of the procurement process to help NHS organizations obtain quality services and supplies.
At Dakota's technology showcase Trusts also heard from Peter Coates, Open Source Programme Head for NHS England. Here is are the materials he shared with us showing the benefits for the NHS set within the wider public sector technology objectives.
Martin Peat and Dawn Jordan, Strategic Projects Team - Open Forum Events' NHS...Alexis May
The document discusses the NHS Strategic Projects Team's experience managing large procurements and their approach to integrated care procurements. The Strategic Projects Team has managed over £4 billion in cost-effective programs since 2009 that have driven innovation in the NHS. They provide a practical view of managing an integrated care procurement, including carrying out an options appraisal, stakeholder engagement, defining outcomes, understanding costs, and establishing evaluation teams early. Lessons learned include taking time for options appraisal, clear stakeholder engagement, articulating needed outcomes, knowing the cost base, and identifying evaluation teams early.
The Isaacus -Digital Health HUB closing event 1.11.2018
Liisa-Maria Voipio-Pulkki / Ministry of Social affairs and Health
"What will come next? How does the future look for us?"
Benefits of engaging with the Specialised Services Commissioning Innovation FundPM Society
The Specialised Services Commissioning Innovation Fund (SSCIF) aims to rapidly evaluate innovative models of care, pathways, technologies and medicines to generate evidence on quality, cost and impact for NHS specialised services. The SSCIF will fund evaluation projects jointly with manufacturers to fill data gaps preventing national commissioning decisions. Successful projects could result in widespread adoption across the NHS and discounted national procurement agreements, presenting an unrivalled opportunity for partnership and adoption of transformative innovations.
The document summarizes the Digital Health Technology Catalyst, a new £35 million funding program in the UK to support the development of digital health technologies. It provides details on the program's first round of funding in 2017, including:
- £8 million available to fund feasibility studies ranging from £50,000-£75,000 or industrial research/experimental development projects ranging from £500,000-£1 million
- Projects must focus on developing digital solutions to improve healthcare outcomes, transform delivery, or make the system more efficient
- Funding is available for SMEs and collaborative projects, which must include an SME lead and start by February 1st, 2018
Presentation by Matt Chapman, Knowledge Transfer Manager, Knowledge Transfer Network at the Health Sector Business Breakfast, 16 March at Northwich Memorial Court
Dr Hakim Yadi, Chief Executive Officer for Northern Health Science Alliance (NHSA) opened the May 24th Ecosystem event with this introduction to Connected Health Cities in the North West.
Colin Cram, Open Forum Events - Open Forum Events' NHS Commissioning and Proc...Alexis May
The NHS is facing significant financial deficits and must achieve £2 billion in procurement savings by 2015-2016. The current strategy involves national initiatives to standardize contracts for high spending categories and establish a Center of Procurement Efficiency. However, the strategy may not achieve full savings and further reform such as mandatory standardization and an integrated procurement organization may be needed. Significant challenges include trust engagement, data sharing, and ensuring savings are realized at the local level.
Dr Samantha Roberts: Increasing adoption of innovation Innovation Agency
The NHS England Innovation and Life Sciences Division aims to increase adoption of innovation in healthcare. It oversees numerous programs from initial research through national implementation. The division is working to better align these programs, support behaviors that increase adoption, improve the supply of high quality innovations, and understand demand. It hopes to focus on how to spread innovations adaptively rather than through rigid, top-down approaches.
New Funding & Development Opportunities for InnovatorsIsabelle Sparrow
On November 8th GM AHSN invited innovators from the region to an event at the Nowgen Centre in Manchester. The event provided information about some of the current funding and support opportunities available to healthcare innovators, including programmes from GM AHSN's Innovation Nexus, SBRI Healthcare and the Business Growth Hub.
The document discusses trends in digital health technologies and healthy lifestyles. It notes that the global well-being market is $2.9 trillion and growing, with self-care and diagnostics markets increasing 8-12% annually. Many people are using social media and mobile devices to search for health information. The document also outlines some challenges to digital health adoption, such as developing open standards and new business models that combine public/private sectors to empower patients and better integrate prevention and care.
The National Institute for Health Research Collaboration for Leadership in Ap...Richard Harding
This document discusses using funding and partnerships to promote innovation in healthcare technology. It highlights projects in the UK that received funding to develop new technologies, including a children's hospital that leveraged over £13 million for an innovation center. It also describes a competition that provided £500,000 to pilot adoption of new technologies. The document outlines European partnerships and events between countries to support collaboration. It promotes an eHealth cluster to connect businesses, healthcare organizations, and academics. Finally, it discusses challenges of introducing new technologies and the need for organizational changes to accommodate disruptions.
Scaling up innovation in healthcare - A Methodology Framework 2015Marc Lange
This presentation introduce a methodology scaling-up developed by "doers and shapers" internationally known for their expertise in eHealth and digital health
Digital Primary Care Maturity Assurance ModelNHS England
The document introduces England's Digital Primary Care Maturity Assurance Model, which assesses the digital maturity of general practices and clinical commissioning groups (CCGs). It collects 107 indicators on areas like data flows, systems usage, and online services from sources including CCG questionnaires, the GP electronic declaration, and HSCIC reports. The model provides different views of the data to support various national programs and objectives. It aims to help CCGs and practices benchmark their digital capabilities and identify areas for investment and collaboration to advance primary care digitization goals. Future development may include linking to secondary care data, shifting the focus from capabilities to usage, and reflecting new models of integrated care.
Bob Ricketts, NHS England - Open Forum Events' NHS Commissioning and Procurem...Alexis May
The document discusses the challenges facing the NHS, including an aging population, rising rates of chronic diseases, increasing costs and resource constraints. It argues that the NHS needs bold, transformative solutions to reshape services at scale and pace. New commissioning approaches like outcome-based population commissioning are proposed to incentivize integrated care, better outcomes and value. Examples from places like Staffordshire aim to develop new payment models and contracts with lead providers to coordinate care for defined populations.
Introduction to the SBRI Competition: Vaccines for Epidemic DiseasesKTN
This document provides information about an upcoming SBRI (Small Business Research Initiative) competition focused on vaccines for epidemic diseases. It summarizes the agenda for an information session on the competition, including welcome remarks, an overview of the UK Vaccine Network and competition aims, and details about the call and timelines. The competition will provide up to £10 million in funding across multiple projects to enhance clinical and regulatory preparedness of vaccines for UKVN priority pathogens or "Disease X". Applications will be accepted from October 11-November 10, 2021 and contracts are expected to be awarded starting April 1, 2022.
Steve Davies, Crown Commercial Service - Open Forum Events' NHS Commissioning...Alexis May
The Crown Commercial Service (CCS) delivers procurement services for the UK public sector, including health organizations. It plays a key role in centralized procurement, providing significant savings for taxpayers. CCS handles over £2.3 billion in annual procurement for the NHS, its largest partner. As a procurement partner, CCS can provide expertise, strategic sourcing of common commodities, and assist with all stages of the procurement process to help NHS organizations obtain quality services and supplies.
At Dakota's technology showcase Trusts also heard from Peter Coates, Open Source Programme Head for NHS England. Here is are the materials he shared with us showing the benefits for the NHS set within the wider public sector technology objectives.
Martin Peat and Dawn Jordan, Strategic Projects Team - Open Forum Events' NHS...Alexis May
The document discusses the NHS Strategic Projects Team's experience managing large procurements and their approach to integrated care procurements. The Strategic Projects Team has managed over £4 billion in cost-effective programs since 2009 that have driven innovation in the NHS. They provide a practical view of managing an integrated care procurement, including carrying out an options appraisal, stakeholder engagement, defining outcomes, understanding costs, and establishing evaluation teams early. Lessons learned include taking time for options appraisal, clear stakeholder engagement, articulating needed outcomes, knowing the cost base, and identifying evaluation teams early.
The Isaacus -Digital Health HUB closing event 1.11.2018
Liisa-Maria Voipio-Pulkki / Ministry of Social affairs and Health
"What will come next? How does the future look for us?"
Benefits of engaging with the Specialised Services Commissioning Innovation FundPM Society
The Specialised Services Commissioning Innovation Fund (SSCIF) aims to rapidly evaluate innovative models of care, pathways, technologies and medicines to generate evidence on quality, cost and impact for NHS specialised services. The SSCIF will fund evaluation projects jointly with manufacturers to fill data gaps preventing national commissioning decisions. Successful projects could result in widespread adoption across the NHS and discounted national procurement agreements, presenting an unrivalled opportunity for partnership and adoption of transformative innovations.
The document summarizes the Digital Health Technology Catalyst, a new £35 million funding program in the UK to support the development of digital health technologies. It provides details on the program's first round of funding in 2017, including:
- £8 million available to fund feasibility studies ranging from £50,000-£75,000 or industrial research/experimental development projects ranging from £500,000-£1 million
- Projects must focus on developing digital solutions to improve healthcare outcomes, transform delivery, or make the system more efficient
- Funding is available for SMEs and collaborative projects, which must include an SME lead and start by February 1st, 2018
The document summarizes the role and activities of Academic Health Science Networks (AHSNs) in the UK. It discusses how AHSNs act as catalysts and connectors to spread healthcare innovations, improve health outcomes, and generate economic growth. It provides examples of innovations that have benefited from AHSN support and been adopted in the NHS. It also outlines goals and initiatives around building partnerships across health and social care systems and supporting life sciences industry and innovation infrastructure.
Putting innovation into practice (NHS vs Widnes Vikings)Richard Harding
The document discusses innovation and the work of the Innovation Agency. It summarizes the agency's support for businesses, including engaging with 543 companies, providing intensive support to 81 companies, and helping create or safeguard over 100 jobs. It also describes the agency's efforts to foster collaboration through events, awards, and aligning with innovation hubs. The agency provides £500k in funding to pump prime adoption of new technologies and supports challenges to NHS procurement requirements to introduce innovation.
The Innovation and Technology Tariff (ITT) aims to incentivize adoption of transformative innovations in the NHS by streamlining pricing and reimbursement. For 2017-19, the first year of the ITT, six themes have been identified that could provide innovation benefits to the NHS at scale. These themes include guided mediolateral episiotomy to minimize obstetric injuries, reducing medication errors, preventing ventilator-associated pneumonia, managing COPD remotely, treating C. difficile infection with frozen fecal transplants, and treating enlarged prostates as outpatients. The ITT operates under both an incentive-based pricing model and a zero-cost model where NHS England covers the cost of approved innovations.
Dr. Anne Blackwood, Chief Executive, Health Enterprise EastIMSTA
Health Enterprise East is an NHS innovation hub that helps NHS organizations and small-to-medium enterprises (SMEs) innovate through services like assessing NHS innovation disclosures, granting commercial licenses, running innovation competitions, and supporting technology projects. It also operates an Innovation Scout Network of over 100 NHS staff across 50 organizations to identify, assess, and promote new innovations. The document discusses drivers of change in medicine like new treatments and technologies. It introduces SBRI Healthcare, a NHS England initiative that funds companies to develop solutions to unmet healthcare needs, and provides two case studies of companies that developed new digital health technologies through SBRI funding.
This document outlines the goals and activities of an organization aimed at spreading innovation in healthcare to improve health outcomes and economic growth. The key points are:
1) The organization aims to spread innovation across the healthcare system, boost the economy through industry growth, and improve equal access to innovative technologies.
2) Activities include supporting the adoption of innovations, developing collaborations between sectors, highlighting opportunities, and bringing together multiple funding streams in the region.
3) The vision is for the region to become a preferred location for healthcare research, trials, collaboration and investment.
1) The Innovation Agency North West Coast connects regional networks of NHS, academic, local authority, third sector, business, and public organizations to improve health, drive down care costs, and stimulate economic growth through partnership and collaboration.
2) It simplifies access to tools, practices, and innovations by grouping them into eight solution themes and supports the adoption and spread of innovations.
3) Barriers to innovation adoption include a lack of entrepreneurship, complex transfer between places, and a need for on-the-ground support teams, as well as local selection of high-value innovations and leadership championing innovation.
Dr. Colman Casey, Director, Health Innovation HubIMSTA
This document summarizes the establishment and progress of the Health Innovation Hub in Ireland. It discusses the commitment to establish a hub to drive collaboration between healthcare and industry. It provides details on companies selected for the initial demonstrator hub projects and trials conducted. It outlines plans for national hub that would span the entire healthcare system and regions to further support innovation and economic growth through healthcare industry partnerships.
Academic Health Science Networks supporting strategic commissioningInnovation Agency
Dr Liz Mear, Chief Executive of the Innovation Agency, presented at NHS Confed 17 on Academic Health Science Networks (AHSNs) supporting strategic commissioning and bringing innovators, commissioners, clinicians and patients to together to develop closer collaboration and a demonstrably clearer understanding of NHS needs and opportunities.
The document provides an overview of innovation and intellectual property (IP) processes at Alberta Health Services (AHS). It discusses definitions of innovation in healthcare and the importance of innovation and IP for health systems. It outlines AHS' IP policy and the processes for evaluating, managing, and commercializing innovations and IP from conception through stages of development. This includes establishing an Innovation Portal for identifying and advancing innovations, and conducting health technology assessments. A case study on a LINAC-MR radiation therapy project demonstrates applying these processes and developing a commercialization plan for an AHS-owned innovation. The document aims to provide guidance to innovators on partnering with AHS to advance healthcare innovations.
Ramon Maspons is the Chief Innovation Officer at AQuAS, an agency that aims to improve Catalonia's healthcare system. AQuAS leads projects using public procurement of innovation (PPI) and pre-commercial procurement (PCP) to foster innovation. One example is THALEA II, a PCP project developing software for remote intensive care support. The consortium includes hospitals from Germany, the Netherlands, Spain, and Finland. Lessons learned from THALEA I and other projects indicate that strong consortium leadership, clear specification of outcomes rather than requirements, and engagement with decision-makers and end-users are keys to success for innovative procurement projects.
The Cell Therapy Catapult was established to help grow the UK's cell therapy industry by addressing barriers to development and commercialization. It provides facilities, expertise, and funding to move cell therapy candidates through development towards clinical trials and commercialization. The Catapult has established GMP manufacturing assessment capabilities, aims to complete 150-200 projects in its first 5 years, and seeks to create 2-4 significant investible cell therapy propositions to help build a £10 billion industry in the UK.
The Role of Health Research Wales in supporting Industry Research in Betsi Cadwaladr University Health Board (BCUHB)
International Clinical Trials Day 20th May 2014
Presented by Rebecca Burns, Health Research Wales, Industry Manager
The Invention for Innovation (i4i) Programme funds collaborative projects between NHS, academia, and industry to advance healthcare technologies and benefit patients. It aims to guide innovative medical technologies through development. Projects can last up to 3 years and receive between £170k to £1.9 million in funding. Since 2010, over 100 projects have been funded totaling over £71 million. The application process involves a two-stage peer review and selection criteria focus on technology innovation, health benefits, and commercialization potential.
This document summarizes the partnership between the National Institute for Health Research (NIHR) and industry to support clinical research and innovation in the UK. Key points:
- NIHR invests over £1 billion annually in research infrastructure including clinical trials facilities to support industry partnerships and clinical research.
- In 2015/16 this infrastructure supported over 11,000 studies, recruited over 320,000 patients, and resulted in over 1,300 collaborations and 576 partnerships with industry worth £149.7 million.
- Examples are provided of NIHR funding programs that support translational research and adoption of novel technologies, helping to bridge the "valley of death" between research and commercialization.
Similar to Mike Kenny - Health Sector Business Opportunities Breakfast Sept 2017 (20)
This document provides a summary of a presentation on statins. It discusses the benefits of statins in reducing cardiovascular events and mortality in both primary and secondary prevention. It addresses several controversies around statins, including their association with diabetes, cognitive impairment, cancer, and hemorrhagic stroke. While some modest risks are noted, the overall benefits of statins in reducing cardiovascular risk are found to outweigh these potential risks. The document emphasizes the importance of statin adherence to achieve optimal outcomes and addresses targets for LDL and non-HDL cholesterol levels according to recent guidelines.
Targeting lipids: a primary and secondary care perspectiveInnovation Agency
Presentations by Dr Sue Kemsley and Dr Gavin Galasko from the first webinar of the Mastering Cholesterol webinar series on Thursday 26 January 2023, focusing on lipid management from a primary and secondary care perspective.
Supporting the optimal detection and management of BP in Primary CareInnovation Agency
Presentation by Jane Briers, Programme Manager - Innovation Agency at the Supporting recovery in Primary Care using Proactive Frameworks for Long Term Conditions event on Thursday 15 September 2022.
Presentation by Dr Lauren Moorcroft, GP Partner - Brookvale Practice at the Supporting recovery in Primary Care using Proactive Frameworks for Long Term Conditions event on Thursday 15 September 2022.
Introduction to Supporting recovery in Primary Care using Proactive Framework...Innovation Agency
Presentation by Julia Reynolds, Associate Director for Transformation - Innovation Agency at the Supporting recovery in Primary Care using Proactive Frameworks for Long Term Conditions event on Thursday 15 September 2022.
Presentation by Paul Brain, Project Manager at the Excel in Health series - Introduction to data webinar on Monday 6 June 2022.
In this session we discussed how SMEs can use data to grow their business and access new opportunities in the market.
Presentations by Mike Kenny, Acting Co-Director of Enterprise and Growth, Innovation Agency and Dr Neil Paul, a GP and Board Member with Cheshire East ICP at the Excel in Health: Understanding the NHS Landscape webinar on Wednesday 11 May 2022.
Developing Effective Remote Consultations in Outpatients webinarInnovation Agency
1) The document discusses strategic plans to increase the use of virtual appointments through video to help restore NHS services and reduce backlogs as directed nationally.
2) Data is presented on the percentage of virtual vs face-to-face appointments by specialty for different regions, showing variation between specialties and trusts in uptake of virtual appointments.
3) Interviews were conducted with NHS staff across roles and specialties to understand the reasons for the differences in uptake of virtual appointments and identify barriers to wider adoption. A separate report from patient interviews also provided feedback.
LCR and Cheshire and Merseyside Health MATTERS networking eventInnovation Agency
Master slide deck from the LCR and Cheshire and Merseyside Health MATTERS networking event on Wednesday 24 November 2021 at Sci-Tech Daresbury Laboratory.
Master slide deck from the Excel in Health webinar series: The NHS landscape presentation.
This webinar identifies the structure of the NHS and its national priorities.
The session will cover the following topics:
Understand the structure of the NHS
Understand the national priorities of the NHS
Recognise the barriers to sale
The document discusses strategies for effective virtual collaboration using Zoom. It covers:
1. Getting familiar with basic Zoom functions and pushing boundaries to achieve results through techniques like choosing the right technology, managing time and atmosphere, addressing technical issues, and designing for inclusivity.
2. Methods for collecting data virtually through polling software, informal tools like chat and reactions, and creative approaches like using glass jars, mountains, push pins, and post-its for feedback.
3. The importance of incorporating fun and enjoyment into virtual meetings by setting challenges, using stories, sharing passions, and exploring improv to promote effective learning.
The document discusses restorative practices and community circles. It provides information on the core principles and processes of restorative circles, including their purposes, structural elements, characteristics, and stages. Circles are presented as an alternative to traditional hierarchical meetings and aim to allow all voices, build relationships, and develop understanding and solutions. Indigenous justice practices of restoration and healing are also honored.
The document outlines an agenda for a webinar hosted by the Innovation Scout network. It will include an introduction to the Innovation Scout network, a presentation from an advocacy link worker, a Q&A session, and wrap up. Attendees are encouraged to tweet with specific hashtags and email the contact for follow up discussions. The Innovation Scout network is a community of practice that was relaunched in 2019 to support innovation in health and social care through tools, culture change, entrepreneurial skills development, and networking. It has over 80 members across the North West Coast region working on healthcare innovation.
DECLARATION OF HELSINKI - History and principlesanaghabharat01
This SlideShare presentation provides a comprehensive overview of the Declaration of Helsinki, a foundational document outlining ethical guidelines for conducting medical research involving human subjects.
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Travel vaccination in Manchester offers comprehensive immunization services for individuals planning international trips. Expert healthcare providers administer vaccines tailored to your destination, ensuring you stay protected against various diseases. Conveniently located clinics and flexible appointment options make it easy to get the necessary shots before your journey. Stay healthy and travel with confidence by getting vaccinated in Manchester. Visit us: www.nxhealthcare.co.uk
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
10 Benefits an EPCR Software should Bring to EMS Organizations Traumasoft LLC
The benefits of an ePCR solution should extend to the whole EMS organization, not just certain groups of people or certain departments. It should provide more than just a form for entering and a database for storing information. It should also include a workflow of how information is communicated, used and stored across the entire organization.
Are you looking for a long-lasting solution to your missing tooth?
Dental implants are the most common type of method for replacing the missing tooth. Unlike dentures or bridges, implants are surgically placed in the jawbone. In layman’s terms, a dental implant is similar to the natural root of the tooth. It offers a stable foundation for the artificial tooth giving it the look, feel, and function similar to the natural tooth.
How to Control Your Asthma Tips by gokuldas hospital.Gokuldas Hospital
Respiratory issues like asthma are the most sensitive issue that is affecting millions worldwide. It hampers the daily activities leaving the body tired and breathless.
The key to a good grip on asthma is proper knowledge and management strategies. Understanding the patient-specific symptoms and carving out an effective treatment likewise is the best way to keep asthma under control.
5-hydroxytryptamine or 5-HT or Serotonin is a neurotransmitter that serves a range of roles in the human body. It is sometimes referred to as the happy chemical since it promotes overall well-being and happiness.
It is mostly found in the brain, intestines, and blood platelets.
5-HT is utilised to transport messages between nerve cells, is known to be involved in smooth muscle contraction, and adds to overall well-being and pleasure, among other benefits. 5-HT regulates the body's sleep-wake cycles and internal clock by acting as a precursor to melatonin.
It is hypothesised to regulate hunger, emotions, motor, cognitive, and autonomic processes.
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
2. Idea Proof of concept Adoption Spread
Innovation and Technology Payment
Central reimbursement of innovative products, services
and technologies
NHS Innovation Accelerator
Supporting a small number of fellows to spread
their innovations in the NHS
Accelerated Access Partnership
Comprised of cross health economy stakeholders, supporting the development of
transformative products, services and technologies via existing routes
NHS Apps Library
Setting standards for apps looking to be
used in the NHS
Health Apps Briefing (NICE)
Assessment of the economic and
efficacy of apps
Test Beds (NHSE)
Pioneering & evaluating use of novel combinations of interconnected devices
Small Business Research Initiative (NHSE)
Provides funding to develop innovative ideas to
NHS problems
Invention for Innovation
Provides funding for development
of prototypes
There are a number of initiatives supporting the identification and adoption of
innovative products, services and technologies
3. • Test Beds
• 5 NHSE
• 2 NHSE and Innovate UK
• Wave 2 in progress
• SBRI Health
• National Innovation Accelerator
• Innovation Technology Payment
• Accelerated Access Partnership
Opportunities for Industry:
nationally supported, locally delivered
4. NHS England funded initiative led by the AHSN’s to develop technology
solutions for known healthcare challenges
• Up to £100,000 of funding for Phase one (feasibility) and up to £1m for
Phase Two (development)
• Last call closed on 6th Sept 2017 and was for:
• Applications for innovations that can enhance the screening, diagnosis or management of
cancer
• Prev calls have included –
• Improving patient flow to maximise operational efficiency in the Acute Sector
• Reducing pressure on Urgent and Emergency care
• Minimising the impact of falling
SBRI Healthcare
6. • Supports NHS Adoption of innovation by removing financial or procurement barriers to
uptake of innovative products or technologies
• Competitive process to identify innovations and technologies offering the greatest
quality and efficiency benefits with wider adoption
• Medical devices, digital platforms and technologies
• Applicants can be from healthcare, academia, commercial or voluntary sectors
• Maximise learning and foster culture change
• ITP is specifically focused on low cost & high impact innovations which can deliver
significant patient outcomes and savings to the NHS
• Delivered in partnership with AHSNs, sponsors, national & international experts
• Agreed payment mechanism or procurement will be operational from April 2018
The Innovation and Technology Payment (ITP)
7. The Accelerated Access Review recommended that a network of Innovation Exchanges
could play a key role in supporting the adoption and uptake of healthcare innovation.
• Hosted by AHSNs, Innovation Exchanges will be a central place that stakeholders can go
to for information, guidance and support.
• Their core functions will include:
1) Identifying need and communicating regional priorities – Help innovators understand what
and where are the healthcare demands, and the evidence requirements
2) Signposting – Act as a ‘first port of call for information’
i. Direct innovators to additional support or market access
ii. Direct patients towards information about trials and pilots in the region, or
new products
iii. Offer practical support to commissioners/providers on uptake, collaboration
opportunities, dissemination of best practice
3) Validation in a real world setting – Broker regional partnerships with commissioners and
providers to offer real world testing opportunities
4) Spread and adoption of innovation across the system – Support scaling up of innovations
which are promising on a local level
Accelerated Access Partnership
8. Speeding up access to innovation
The funding is split into four packages. These are:
• £39m for the AHSN Network, enabling them to locally assess the benefits
of new technologies and support NHS uptake of those that deliver real
benefits to patients according to the local need
• A £35m Digital Health Technology Catalyst (over 4yrs) for innovators –
match funding development of digital technologies for patients & NHS
• Up to £6m over the next 3 years to support SMEs with innovative
medicines and devices get the evidence they need by testing in the real
world, building on existing opportunities such as the Early Access to
Medicine Scheme
• A £6m Pathway Transformation Fund which will help NHS organisations
integrate new technologies into everyday practices - help overcome more
practical obstacles such as training staff on how to use new equipment
9. Digital health technology catalyst
First Round :Up to £8 million is on offer for UK businesses to work on innovation projects that tackle
the biggest healthcare challenges.
The aim is to support the development of digital health products that meet NHS needs.
• Feasibility or development projects that advance digital health or digitally-enabled medical
technologies. These should:
• improve patient outcomes, such as through better clinical decision-making and supporting them to
manage their own care
• offer new approaches to healthcare that transform its delivery
• reduce the demand on the health system, make it more efficient and create savings
• Opened 31/7/17 & deadline for registrations is 4 October 2017
• Feasibility studies £50k to £75k - up to one year
• Industrial research & experimental development projects £500k - £1 mill - up to 3 yrs
• work alone or in collaboration with other organisations, but projects must be led by a UK-based SME
• you could get up to 70% of your eligible project costs
• projects must start by 1 February 2018
10. Innovate UK Funding
The competitions cover the 4 core sector groups, plus the
Open programme, with each sector group having 2
competitions in the year.
The submission deadlines are:
• Emerging and Enabling Technologies – 08.11.17
• Health and Life Sciences – 06.12.17
• Infrastructure Systems – 13.09.17 and 14.03.18
• Manufacturing and Materials – 17.01.18
• Open Programme – 07.02.18
• Also piloting Accelerator fund – joint grant and VC funding
11. Resources
• SBRI Healthcare Competitions Info
• https://sbrihealthcare.co.uk/
• Accelerated Access Review Report
• https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/565072/AAR_final.pdf
• Digital health technology catalyst 2017 round 1
• https://apply-for-innovation-funding.service.gov.uk/competition/50/overview
• Innovate UK Competitions information (Medicines
Manufacturing, Biomedical Catalysts etc)
• https://apply-for-innovation-funding.service.gov.uk/competition/search